Less than a decade after its founding in 1896 in Basel, Switzerland, Roche established U.S. operations in New York City in 1905. In 1929, the company moved to Nutley, N.J., now the headquarters of its U.S. Pharmaceuticals unit. Today, the Roche Group is one of the world’s foremost innovation-driven healthcare enterprises and ranks among the global leaders in pharmaceuticals and diagnostics. Collectively, the two Roche businesses (including Genentech, the South San Francisco-based biotech leader, and the New York/New Jersey operations of Japanese drug firm Chugai, in which Roche is the majority owner) employ more than 15,000 people at a dozen sites in the United States.
Roche’s commitment to research and development has been key to its scientific and commercial success. In 2006, the company invested 17.7 percent of worldwide sales –or about $6 billion - in the discovery and development of new products and technologies.
Roche recognizes the importance of corporate citizenship and integrates the company’s business goals and objectives through a multifaceted process of community involvement, charitable contributions, and partnerships. For example, the Roche Patient Assistance Foundation provides our drugs for free to thousands of patients each year who lack prescription coverage and the means to pay for the medications they need. Since 2000, the company has provided free Roche products to patients in need valued at over $821 million (based on Wholesale Acquisition Cost or list price).
For more information, access www.rocheusa.com or www.roche.us